Castle Biosciences Obtains $11,800,000 New Financing

  • Feed Type
  • Date
    8/14/2014
  • Company Name
    Castle Biosciences
  • Mailing Address
    2014 San Miguel Dr. Friendswood, TX 77546 USA
  • Company Description
    Any time someone is diagnosed with cancer, many decisions have to be made regarding development of an optimal personalized treatment plan. Development of an optimal treatment plan requires accurate information regarding the diagnosis, prognosis and predicted responsiveness of a specific tumor – in other words accurate staging of the tumor.
  • Website
    http://www.castlebiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,800,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funds will be used to expand clinical availability of Castle Biosciences’ portfolio of practice-changing cancer diagnostic tests, including DecisionDx-Melanoma, its test to determine metastatic risk in patients with melanoma.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

By posting a comment, you agree to our terms and conditions.